The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 study of nivolumab monotherapy versus nivolumab combined with ipilimumab in patients with metastatic or unresectable gastrointestinal stromal tumor (GIST).
 
Arun S. Singh
Consulting or Advisory Role - Daiichi Sankyo; Lilly
Speakers' Bureau - Eisai; Lilly
Travel, Accommodations, Expenses - Daiichi Sankyo; Eisai; Lilly
Other Relationship - pdox
 
Bartosz Chmielowski
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Genentech/Roche; Immunocore; Merck
Speakers' Bureau - Genentech/Roche; Janssen Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Janssen; Merck
 
J. Randolph Hecht
No Relationships to Disclose
 
Lee S. Rosen
Research Funding - Bayer (Inst); Lilly (Inst); Pfizer (Inst); PsiOxus Therapeutics (Inst); Regeneron (Inst)
 
Xiaoyan Wang
No Relationships to Disclose
 
Sandra Brackert
No Relationships to Disclose
 
Carlos R. Adame
No Relationships to Disclose
 
Paulina J Linares
No Relationships to Disclose
 
Elena Schink
No Relationships to Disclose
 
Lisa Marie Marubio
Employment - Bristol-Myers Squibb
 
Frederick C. Eilber
Stock and Other Ownership Interests - pdox